| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1999;99:845-846.)
© 1999 American Heart Association, Inc.
Cardiovascular News |
1 Circulation Newswriter
More than a year after the Batista procedure jumped
into national headlines, experts at the 71st Scientific Sessions of the
American Heart Association meeting in Dallas, Tex, reported both good
and bad news about the radically different surgery. Patrick McCarthy,
MD, cardiovascular surgeon at the Cleveland Clinic in
Cleveland, Ohio, said 72% of patients who had the procedure have
survived
2 years. "The good news is that it works well in some
patients," he said. "How often it will work well and how it will
last remain undetermined.
"The troublesome news is that it sometimes doesn't work," said McCarthy. One reason is that although the procedure improves the way the heart contracts, it detracts from the muscle's relaxation. In addition, fibrotic hearts will not respond as well with improved contractions. "Sometimes it is just too late for some patients," McCarthy said. He predicted that the Batista procedure will become the Batista concept. Already, he said, one company is developing a device that will simulate the benefits of the operation without opening the chest or discarding heart tissue.
Akira T. Kawaguchi, MD, a Japanese surgeon from Tokai University
who learned the procedure from Brazilian surgeon Randas Batista, MD,
said the operation is used in his country, where transplant is
virtually impossible because of laws governing organ donation. "It is
used for socioeconomic reasons in Brazil and social reasons in
Japan," said Kawaguchi. Batista, who himself appeared at an AHA press
conference, agreed, saying that in the United States, surgery and
transplants
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |